Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "OneSource receives EIR with 'Voluntary Action Indicated' classification from USFDA for its BLD Facility".
Press Release Jan 28 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
OneSource Specialty Pharma Limited on 6ix
In the deck
Later from OneSource Specialty Pharma
- Press Release Jan 29 2025
- Press Release Feb 28 2025
- Press Release Apr 10 2025
- Press Release May 05 2025
- Onesource Specialty Pharma Limited Press Release Jun 10 2025
Follow OneSource Specialty Pharma into a list and get an email when it puts out news.
Follow OneSource Specialty Pharma